News | Falcon Capital

Dec 29, 2020
3 min

Moleculin Announces Annamycin Receives FDA Orphan Drug Designation for Soft Tissue Sarcomas

HOUSTON, Dec. 29, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage...

Dec 27, 2020
4 min

CNS Pharmaceuticals Featured in Syndicated Broadcast Covering Recent FDA Approval of IND Application

HOUSTON, Dec. 28, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – CNS Pharmaceuticals, Inc. (NASDAQ: CNSP), a biopharmaceutical company...

Dec 22, 2020
3 min

Atari Founder & Technology Innovator Nolan Bushnell Joins Esports Technologies as Strategic Advisor

Company Continues Expansion With Addition of Atari Founder and First Tech Incubator; Two Top Executives LAS VEGAS, Dec. 23, 2020...

Dec 18, 2020
2 min

CNS Pharmaceuticals Call to Discuss FDA IND Approval and Phase 2 Trial for Berubicin Today at 8:30am

HOUSTON, Dec. 18, 2020 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company...

Dec 17, 2020
5 min

Logiq Launches Pilot Program to Provide Mobile Fintech Services in Exclusive Strategic Alliance with

Indonesian National Cooperative, KMSB NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Logiq, Inc. (OTCQX: LGIQ), a global provider of...

Dec 17, 2020
5 min

Logiq Begins Next Phase of Micro-Lending Program Designed to Provide Mobile Fintech Services to

5 Million Contract and Delivery Drivers NEW YORK, Dec. 18, 2020 (GLOBE NEWSWIRE) -- Logiq, Inc. (OTCQX: LGIQ), a global provider of...

Dec 17, 2020
4 min

CNS Pharmaceuticals Announces FDA Approval of IND Application

for its Brain Cancer Drug Candidate Berubicin IND Approval Marks Key Step in Beginning of Potentially Pivotal Trial of Berubicin HOUSTON,...

Dec 17, 2020
4 min

Moleculin Announces FDA Permission to Begin Clinical Study of Annamycin for Sarcoma Lung Metastases

HOUSTON, Dec. 17, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage...

Dec 14, 2020
2 min

Boxlight Wins Best of Show Awards at ISTE

LAWRENCEVILLE, Ga.--(BUSINESS WIRE)--Boxlight Corporation (Nasdaq: BOXL), a leading provider of interactive technology, digital signage...

Dec 7, 2020
2 min

Boxlight Announces Three New Product Awards

LAWRENCEVILLE, Ga.--(BUSINESS WIRE)--Boxlight Corporation (Nasdaq: BOXL), a leading provider of interactive technology, digital signage...

Dec 3, 2020
3 min

Moleculin To Present Antitumor Activity of Annamycin in Combination with Ara-C

in AML at American Society for Hematology Annual Conference HOUSTON, Dec. 3, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX)...

Dec 2, 2020
5 min

StereoVision Imaging, Industry Leader in 4D FMCW LiDAR Technology, Adds Five New Continuation Patent

to Extensive IP Portfolio CALABASAS, Calif., Dec. 03, 2020 (GLOBE NEWSWIRE) -- StereoVision Imaging, Inc. (SVI) has been granted four new...

Dec 1, 2020
1 min

Logiq Is Full Of Interesting Growth And Synergy Opportunities

Source: https://seekingalpha.com/article/4392625-logiq-is-full-of-interesting-growth-and-synergy-opportunities

Dec 1, 2020
3 min

Moleculin Announces FDA Approves 3 Rare Pediatric Disease Designations for WP1066

Priority Review Vouchers subject to approved NDA HOUSTON, Dec. 1, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin...

Nov 30, 2020
6 min

QCI and Meraglim Join Forces to Deliver Capital Markets Risk Analysis Powered by QCI’s Mukai Quantum

LEESBURG, Va., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Quantum Computing Inc. (OTCQB: QUBT) (QCI), the technology leader in quantum-ready...

Nov 24, 2020
5 min

CNS Pharmaceuticals Featured in Syndicated Broadcast Covering Recent Announcements

for Glioblastoma Multiforme (GBM) Therapy HOUSTON, Nov. 24, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – CNS Pharmaceuticals, Inc....

Nov 19, 2020
4 min

Moleculin Announces New Data Demonstrating Synergistic Antitumor Activity of Annamycin Combination

with Ara-C in AML Experimental data to be presented at American Society for Hematology Annual Conference HOUSTON, Nov. 19, 2020...

Nov 19, 2020
5 min

CNS Pharmaceuticals (NASDAQ: CNSP) Outlines Plans for Advancing Drug It Hopes Will Beat Deadly Brain

November 19, 2020 Biotechnology developer CNS Pharmaceuticals is working to advance the clinical trials of a novel brain cancer-fighting...

Nov 18, 2020
2 min

CNS Pharmaceuticals and WPD Pharmaceuticals to Contribute Sponsorship to 2020 SNO Virtual Meeting

HOUSTON, Nov. 19, 2020 /PRNewswire/ -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company...

Nov 18, 2020
3 min

Boxlight Announces Mark Starkey as President

LAWRENCEVILLE, Ga.--(BUSINESS WIRE)--Boxlight Corporation (Nasdaq: BOXL), a leading provider of interactive technology solutions, today...